John M. Dineen
CIK 1645270 · last filed 2026-06-04
John M. Dineen is a corporate insider who has filed 39 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for CTSH, was dated Jun 4, 2026. Across all open-market trades the lifetime net is +$1.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $3.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.45M
4
39
$1.53M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CTSH | Director | 1,827 | $52.17 | $95.3K | $0 | 23 | 2026-06-04 |
| LRCX | Director | 9,135 | $366.81 | $3.35M | $0 | 3 | 2025-11-10 |
| Syneos Health, Inc. (SYNH) Delisted | Director | 0 | $42.98 | $0 | $513.7K | 8 | 2023-09-28 |
| MERRIMACK PHARMACEUTICALS INC (MACK) Delisted | Director | 100,000 | $15.13 | $1.51M | $1.01M | 5 | 2018-06-15 |
Recent Filings
39 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-04 | CTSH | Grant (A) | — | $0 | EDGAR |
| 2026-05-29 | CTSH | Grant (A) | — | $0 | EDGAR |
| 2026-03-02 | CTSH | Grant (A) | — | $0 | EDGAR |
| 2025-12-01 | CTSH | Grant (A) | — | $0 | EDGAR |
| 2025-11-10 | LRCX | Grant (A) | +1,635 | $0 | EDGAR |
| 2025-08-28 | CTSH | Grant (A) | — | $0 | EDGAR |
| 2025-06-05 | CTSH | Grant (A) | — | $0 | EDGAR |
| 2025-05-30 | CTSH | Grant (A) | — | $0 | EDGAR |
| 2025-02-28 | CTSH | Grant (A) | — | $0 | EDGAR |
| 2024-12-02 | CTSH | Grant (A) | — | $0 | EDGAR |